GENB

Generate Biomedicines

GENB

Market cap $1.68B

Upgrade to unlock

Positive

Neutral

Negative

Sentiment 3-Months

Positive

Neutral 50%

Negative

The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Ark Invest bought shares of MercadoLibre, Intellia Therapeutics, and Generate Biomedicines on Monday. MercadoLibre and Intellia Therapeutics are trading 33% and 45% below their 52-week highs, respectively.

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market

One IPO and six SPACs came to market this past week, and one major issuer joined the pipeline as February comes to a close. One large IPO is currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Street research is expected for seven companies in the week ahead, and one lock-up period will be expiring.

U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market

See News Rankings